Large-scale testing (Phase 3)Study completedNCT00511147What this trial is testingIGIV Study for Chronic ITP Patients Ages 3-70Who this might be right forIdiopathic Thrombocytopenic Purpura Grifols Biologicals, LLC 64
Not applicableEnded earlyNCT01386723What this trial is testingEnd of EXTEND: Discontinuation of Medication for Patients With Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Weill Medical College of Cornell University 35
Large-scale testing (Phase 3)Ended earlyNCT04224688What this trial is testingAssess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)Who this might be right forPrimary Immune Thrombocytopenia UCB Biopharma SRL 30
Large-scale testing (Phase 3)Study completedNCT00415532What this trial is testingRomiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic PurpuraWho this might be right forIdiopathic Thrombocytopenic PurpuraThrombocytopeniaThrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)+1 more Amgen 234
Testing effectiveness (Phase 2)Study completedNCT04669600What this trial is testingA Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia (ITP) Bioverativ, a Sanofi company 12
Early research (Phase 1)Study completedNCT00442871What this trial is testingStudy Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal ImpairmentWho this might be right forPurpura, Thrombocytopaenic, Idiopathic GlaxoSmithKline 29
Early research (Phase 1)Study completedNCT00735930What this trial is testingLenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forAnemiaChronic Lymphocytic LeukemiaProlymphocytic Leukemia+3 more National Cancer Institute (NCI) 39
Post-approval studies (Phase 4)UnknownNCT04102033What this trial is testingEltrombopag in Chronic ITPWho this might be right forImmune Thrombocytopenia Assiut University 20
Testing effectiveness (Phase 2)Study completedNCT00424177What this trial is testingRepeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)Who this might be right forPurpura, Thrombocytopaenic, Idiopathic GlaxoSmithKline 66
Early research (Phase 1)Study completedNCT00001630What this trial is testingTreatment of Autoimmune Thrombocytopenia (AITP)Who this might be right forAutoimmune DiseaseAutoimmune Hemolytic AnemiaThrombocytopenia National Heart, Lung, and Blood Institute (NHLBI) 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT02061800What this trial is testingCD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantWho this might be right forChronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more Diane George 14
Not applicableUnknownNCT05630313What this trial is testingGene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in BrazilWho this might be right forVaccine-induced Thrombotic Thrombocytopenia SyndromeGuillain-Barre SyndromeAcute Disseminated Encephalomyelitis+1 more The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 100
Testing effectiveness (Phase 2)WithdrawnNCT05509582What this trial is testingExtension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated CytopeniasWho this might be right forImmune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD National Heart, Lung, and Blood Institute (NHLBI)
Large-scale testing (Phase 3)Looking for participantsNCT06948318What this trial is testingA Continuation Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenic Purpura (ITP) Takeda 150
Large-scale testing (Phase 3)Study completedNCT00370331What this trial is testingRAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With EltrombopagWho this might be right forPurpura, Thrombocytopaenic, Idiopathic GlaxoSmithKline 197
Testing effectiveness (Phase 2)Study completedNCT04278924What this trial is testingTAK-079 in Adults With Persistent/Chronic Primary Immune ThrombocytopeniaWho this might be right forPrimary Immune Thrombocytopenia Takeda 41
Large-scale testing (Phase 3)Study completedNCT00828750What this trial is testingClinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)Who this might be right forIdiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic GlaxoSmithKline 19
Post-approval studies (Phase 4)Study completedNCT03119974What this trial is testingRate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITPWho this might be right forPersistent or Chronic ITP Assistance Publique - Hôpitaux de Paris 48
Not applicableLooking for participantsNCT04902807What this trial is testingConception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and InflammationWho this might be right forAutoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more Institut National de la Santé Et de la Recherche Médicale, France 500
Large-scale testing (Phase 3)Ended earlyNCT01226524What this trial is testingThe Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP)Who this might be right forChildhood Chronic Immune Thrombocytopenia Hadassah Medical Organization 7